
Sanofi Consumer Healthcare India (SANOFICONR) Share Price Near 52-Week Low as Price Action and Valuation Draw Attention
Updated: 22 Oct 2026 • 9:55 am
Posted by:
Sanofi Consumer Healthcare India Share Price was Rs 3,385.40, up 0.83%, and stayed near its 52-week low while market capitalisation stood at Rs 7,732.76 crore. Univest data shows the move is relevant for price action and valuation tracking.
Sanofi Consumer Healthcare India Share Price opened the morning trade at Rs 3,252.25 and last traded at Rs 3,385.40, while being positioned close to its 52-week low. The stock’s move of Rs 27.80, or 0.83%, kept Sanofi Consumer Healthcare India Share Price in focus as traders compared the day’s range with its yearly low zone. Market capitalisation was Rs 7,732.76 crore, placing the company in the mid-cap range within healthcare. Univest data confirms the price event, but it does not establish a company-specific catalyst. That makes Sanofi Consumer Healthcare India Share Price a stock-news screen for investors studying Sanofi Consumer Healthcare India Share Price Today, Sanofi Consumer Healthcare India Stock News and the broader Sanofi Consumer Healthcare India Share Price update.
At this point, the market is reading Sanofi Consumer Healthcare India Share Price through a simple lens: the stock is trading well below its 50 DMA of Rs 3,792.69 and 200 DMA of Rs 4,317.01, yet the day’s recovery from the open shows that buying interest has still appeared intraday. The latest Sanofi Consumer Healthcare India Stock News therefore centres on price behaviour, valuation and sector context rather than any verified event trigger. For readers tracking Sanofi Consumer Healthcare India Share Price Today, the key question is whether the share price can stabilise near support while the broader Sanofi Consumer Healthcare India Share News narrative stays anchored to fundamentals, not speculation.
Sanofi Consumer Healthcare India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,385.4 |
| Previous Close | Rs 3,357.6 |
| Today's Move | +Rs 27.8 (+0.83%) |
| Open | Rs 3,252.25 |
| High | Rs 3,415.6 |
| Low | Rs 3,252.25 |
| Market Capitalisation | Rs 7,732.76 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) traded at Rs 3,385.4 versus the previous close of Rs 3,357.6, a rise of 0.83%. The stock opened at Rs 3,252.25, reached a high of Rs 3,415.6, touched a low of Rs 3,252.25.
Sanofi Consumer Healthcare India Share Price today is defined by a wide intraday swing and a modest positive move against the previous close of Rs 3,357.60. The stock opened at Rs 3,252.25, touched a high of Rs 3,415.60 and a low of Rs 3,252.25, before last trading at Rs 3,385.40. That means Sanofi Consumer Healthcare India Share Price was holding above the opening level and above the previous close, even after first dipping to the day low. In near 52-week low situations, the market typically watches whether price action can reclaim short-term support, and here the move shows a cautious bounce rather than a decisive trend shift.
From a market-news angle, Sanofi Consumer Healthcare India Share Price Today is interesting because the stock is still far below the 50 DMA and the 200 DMA. That keeps the share in a weak medium-term structure, even though today’s percentage move was positive. Univest notes that such price action can attract attention in the Indian stock market and among stocks in news, but the latest data alone does not establish why the stock is trending this way.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,732.76 crore |
| P/E Ratio | 29.07x |
| P/B Ratio | 22.23x |
| ROE | 73.2% |
| ROCE | 98.11% |
| EPS | Rs 115.5 |
| Book Value Per Share | Rs 151.07 |
| Dividend Yield | 2.23% |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) fundamental metrics show P/E 29.07x, P/B 22.23x, ROE 73.2%, ROCE 98.11%. These figures provide context only and are not a buy or sell signal.
Sanofi Consumer Healthcare India Ltd. has a market capitalisation of Rs 7,732.76 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.07x, P/B at 22.23x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 73.2% and ROCE of 98.11%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 115.5, book value per share of Rs 151.07, dividend yield of 2.23%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.67x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.07x |
| Benchmark Median P/E | 26.67x |
| Benchmark Average P/E | 38.83x |
| Benchmark P/E Range | 0x to 616.23x |
| Company P/B Ratio | 22.23x |
| Benchmark Median P/B | 2.67x |
| Company ROE | 73.2% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 98.11% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 7,732.76 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 29.07x, which is above the benchmark median of 26.67x, a difference of +9%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROE of 73.2%, which is above the benchmark median of 11.23%, a difference of +551.83%. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROCE of 98.11%, which is above the benchmark median of 13.17%, a difference of +644.95%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Aarti Pharmalabs Ltd. | AARTIPHARM | 7,561.34 | 35.81 | 3.49 | 8.5 | 10.77 |
| SYMBIOTEC PHARMALAB LTD | SYMBIOTEC | 7,942.7 | 70.74 | 5.18 | 11.22 | 12.41 |
| Suven Life Sciences Ltd. | SUVEN | 8,211.27 | 0 | 14.13 | -101.8 | -78.71 |
| Procter & Gamble Health Ltd. | PGHL | 8,382.11 | 23.49 | 13.62 | 62.18 | 84.86 |
| Supriya Lifescience Ltd. | SUPRIYA | 6,776.65 | 34.16 | 5.55 | 19.06 | 25.3 |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 29.07x compared with the displayed peer median of 34.16x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 73.2% compares with a peer median of 11.22% across the companies shown in the table. ROCE stood at 98.11% versus the displayed peer median of 12.41%, providing a capital-efficiency comparison. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a market capitalisation of Rs 7,732.76 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Sanofi Consumer Healthcare India
- Sanofi Consumer Healthcare India Share Price is near its 52-week low, so price action is central to the current debate.
- Sanofi Consumer Healthcare India Share Price Today is still below the 50 DMA and 200 DMA, which keeps the trend structure weak.
- Sanofi Consumer Healthcare India Fundamental Analysis shows high ROE, ROCE and EPS, which support investor attention.
- Sanofi Consumer Healthcare India Share Price also looks higher-valued on P/B compared with the same-industry median.
- Sanofi Consumer Healthcare India Stock News is being watched for sector positioning rather than a verified catalyst.
About Sanofi Consumer Healthcare India
Sanofi Consumer Healthcare India Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of a business category that typically focuses on consumer health products and related pharmaceutical offerings, with market attention often shaped by brand strength, product mix and profitability. For Sanofi Consumer Healthcare India Share Price readers, the key point is that the company combines a large market capitalisation with strong return ratios and a premium valuation profile.
Its reported financial context includes quarterly revenue of Rs 235.7 crore for Jun 2026, EPS of 115.5, book value of Rs 151.07 and dividend yield of 2.23. These figures make Sanofi Consumer Healthcare India Share Price relevant not only as a market-move story but also as a company-overview story. In Univest research, investors often compare such businesses across sector peers to understand whether price weakness reflects market sentiment, valuation re-rating or a broader stock-performance reset.
Track Sanofi Consumer Healthcare India Share Price on Univest
Use Sanofi Consumer Healthcare India Ltd. (SANOFICONR) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Readers can track Sanofi Consumer Healthcare India Share Price on Univest for live share price updates, technical indicators, fundamental ratios, shareholding pattern views, 52-week levels and market insights. The platform helps users follow Sanofi Consumer Healthcare India Share Price Today alongside sector benchmarks, peer comparison and broader stock analysis in one place. Univest also keeps the latest Sanofi Consumer Healthcare India Stock News, Sanofi Consumer Healthcare India Share News and market-cap context available for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Sanofi Consumer Healthcare India Share Price near a 52-week low?
Ans. Sanofi Consumer Healthcare India Share Price is near a 52-week low because the stock is trading well below its 50 DMA and 200 DMA. Univest data confirms the price event, but it does not establish a company-specific catalyst.
What is Sanofi Consumer Healthcare India Share Price today?
Ans. Sanofi Consumer Healthcare India Share Price today last traded at Rs 3,385.40, up Rs 27.80 or 0.83% from the previous close of Rs 3,357.60. It also touched a high of Rs 3,415.60.
What does Sanofi Consumer Healthcare India Fundamental Analysis show?
Ans. Sanofi Consumer Healthcare India Fundamental Analysis shows a market cap of Rs 7,732.76 crore, P/E of 29.07, P/B of 22.23, ROE of 73.2%, ROCE of 98.11%, EPS of 115.5 and dividend yield of 2.23.
How does Sanofi Consumer Healthcare India compare with industry benchmarks?
Ans. The stock’s P/E of 29.07 is above the industry median of 26.67 but below the average of 38.83. Its P/B of 22.23 is far above the median of 2.67, while ROE and ROCE are well above benchmark levels.
Is Sanofi Consumer Healthcare India Share Price expensive?
Ans. On P/B, Sanofi Consumer Healthcare India Share Price looks higher-valued versus the industry median. However, the company also shows strong ROE and ROCE, so valuation should be read alongside profitability rather than in isolation.
What should investors watch next in Sanofi Consumer Healthcare India Share Price?
Ans. Investors should watch whether Sanofi Consumer Healthcare India Share Price can stabilise above the day’s lower range and improve relative to the 50 DMA. The sector benchmark and peer comparison also remain important for context.
Recent Articles

Infosys Dividend 2026: Rs 26 Per Share Interim Payout, Record Date, Q2 Profit Up 6.23% and What Shareholders Should Know
23 October 2026

Ambit Capital Telecom Picks: Why the Brokerage Backs Airtel, Vodafone Idea and Indus Towers With Buy Ratings and Higher Targets
23 October 2026

Delhi Pollution Curbs: Can They Be a Game-Changer for Auto and EV Stocks From Ather Energy to TMPV?
23 October 2026

Swiggy vs Eternal Shares Compared: Which Is the Better Stock After Q2 FY27 Results as Blinkit Profit Meets Instamart Loss?
23 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Infosys Dividend 2026: Rs 26 Per Share Interim Payout, Record Date, Q2 Profit Up 6.23% and What Shareholders Should Know
Ambit Capital Telecom Picks: Why the Brokerage Backs Airtel, Vodafone Idea and Indus Towers With Buy Ratings and Higher Targets
Delhi Pollution Curbs: Can They Be a Game-Changer for Auto and EV Stocks From Ather Energy to TMPV?
Swiggy vs Eternal Shares Compared: Which Is the Better Stock After Q2 FY27 Results as Blinkit Profit Meets Instamart Loss?
Himadri Speciality Share Price Posts Its Biggest Weekly Fall Since 2008: What Q2 FY27 Margins, Valuation and Guidance Say

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





